| Particulars |
|
|
|
|
Company Name
| Astrazeneca Pharma India Ltd
|
Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
5.00 |
B.V. (₹) |
308.10 |
| Sales(₹ Cr.) |
1,716.29 |
NP (₹ Cr.) |
175.13 |
| NP Var% |
17.00 |
Div% |
1,600.00 |
| CPS(₹) |
86.00 |
EPS (₹) |
70.10 |
| Traded Value(₹ Lakhs) |
61.58 |
52 Week High |
10,653.00 |
| 52 Week Low |
6,222.00 |
Price BSE |
8,765.00 |
| Price NSE |
8,785.00 |
Market Capital (₹ Cr.) |
21,912.75 |
| P/C Ratio |
101.90 |
P/E Ratio |
125.10 |
| Price Vs.BV |
28.45 |
|
| Latest Quarter |
| Year End |
202503 |
Sales (₹ Cr.) |
480.48 |
| NP(₹ Cr.) |
62.27 |
NP Var % |
58.00 |
| Trailing Twelve Months |
| Year End |
202503 |
Sales |
1,484.51 |
| OPM |
4.15 |
NP |
128.73 |
| NP Var% |
17.49 |
EPS |
70.05 |
| PE |
125.13 |
|
|